• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE Back to Search Results
Model Number M00564910
Device Problems Break (1069); Human-Device Interface Problem (2949); Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/08/2022
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.(b)(4).The complainant indicated that the stent remains implanted and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2022 that an ultraflex tracheobronchial covered distal release stent was implanted to release the external pressure caused by the malignant tumor in the longitudinal wall of the main trachea during a stent placement procedure performed on (b)(6) 2022.On (b)(6) 2022, post stent placement, it was noted that the stent migrated distally.The physician attempted to reposition the stent by grabbing the stent retention sutures; however, the stent sutures were damaged.The physician then grabbed the metal part of the stent and repositioned the stent back to its original position.The original stent remains implanted and the procedure was completed.In the physician's assessment, concomitant use of radiation therapy may have caused the tumor to shrink and the stent to migrate more easily.There were no patient complications reported due to this event.The patient's current condition was reported to be stable.
 
Event Description
It was reported to boston scientific corporation on january 11, 2022 that an ultraflex tracheobronchial covered distal release stent was implanted to release the external pressure caused by the malignant tumor in the longitudinal wall of the main trachea during a stent placement procedure performed on (b)(6) 2022.On (b)(6) 2022, post stent placement, it was noted that the stent migrated distally.The physician attempted to reposition the stent by grabbing the stent retention sutures; however, the stent sutures were damaged.The physician then grabbed the metal part of the stent and repositioned the stent back to its original position.The original stent remains implanted and the procedure was completed.In the physician's assessment, concomitant use of radiation therapy may have caused the tumor to shrink and the stent to migrate more easily.There were no patient complications reported due to this event.The patient's current condition was reported to be stable.**additional information received on february 01, 2022**.The ultraflex tracheobronchial stent was implanted to treat a 7cm malignant tumor in the longitudinal wall of the main trachea.The patient's anatomy was not tortuous and was not dilated prior to stent placement.The stent was repositioned to its original position with forceps.Furthermore, granulation tissue was noted on the proximal side of the stent so an additional stent will be placed at a later date.
 
Manufacturer Narrative
Blocks b5, d4 (lot number, expiration date), h4, h6 (device code) have been updated with additional information received on february 01, 2022.Block h6: medical device problem code a010402 captures the reportable event of stent migration.Medical device problem code a0401 captures the reportable event of stent suture break.Medical device problem code a22 captures the reportable event of stent overgrowth.Impact code f23 captures the additional intervention of stent repositioning.Conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complainant indicated that the stent remains implanted and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX TRACHEOBRONCHIAL
Type of Device
PROSTHESIS, TRACHEAL, EXPANDABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key13440553
MDR Text Key284968764
Report Number3005099803-2022-00430
Device Sequence Number1
Product Code JCT
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K012883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/27/2022
Device Model NumberM00564910
Device Catalogue Number6491
Device Lot Number0026254612
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/27/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-